Published in Virchows Arch on November 13, 2013
Toll-like receptor 9 expression in the natural history of Barrett mucosa. Virchows Arch (2015) 0.89
Toll-like receptors in esophageal cancer. Front Immunol (2014) 0.88
Nucleic acid-sensing toll-like receptors 3, 7 and 8 in esophageal epithelium, barrett's esophagus, dysplasia and adenocarcinoma. Oncoimmunology (2016) 0.85
Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett's esophagus, dysplasia and adenocarcinoma. Oncotarget (2016) 0.83
Microbiome, innate immunity, and esophageal adenocarcinoma. Clin Lab Med (2014) 0.78
Different Toll-Like Receptor Expression Patterns in Progression toward Cancer. Front Immunol (2014) 0.78
High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patients. Virchows Arch (2017) 0.76
The Expression of Toll-like Receptors in Normal Human and Murine Gastrointestinal Organs and the Effect of Microbiome and Cancer. J Histochem Cytochem (2016) 0.75
Intratumoral lactate metabolism in Barrett's esophagus and adenocarcinoma. Oncotarget (2017) 0.75
Association between Toll-like receptor 7 Gln11Leu single-nucleotide polymorphism and basal cell carcinoma. Biomed Rep (2016) 0.75
Tenascin-C and fibronectin in normal esophageal mucosa, Barrett's esophagus, dysplasia and adenocarcinoma. Oncotarget (2017) 0.75
Nuclear localization of Toll-like receptor 5 in Barrett's esophagus and esophageal adenocarcinoma is associated with metastatic behavior. Virchows Arch (2016) 0.75
Toll-like receptor signalling. Nat Rev Immunol (2004) 34.74
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature (2001) 14.24
Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol (2005) 9.70
The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst (2005) 8.90
Pathogen recognition by the innate immune system. Int Rev Immunol (2011) 5.76
Bacterial biota in the human distal esophagus. Proc Natl Acad Sci U S A (2004) 5.64
Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol (1988) 3.67
Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol (2007) 3.00
Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res (2005) 2.91
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology (2009) 2.55
Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut (2002) 2.16
Toll-like receptors. Curr Biol (2011) 2.06
Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin Exp Immunol (2004) 1.94
Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated. Am J Gastroenterol (2010) 1.90
The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression. Am J Gastroenterol (2000) 1.84
Toll-like receptor 5 engagement modulates tumor development and growth in a mouse xenograft model of human colon cancer. Gastroenterology (2008) 1.70
Toll-like receptors. Curr Protoc Immunol (2007) 1.64
Normal keratinocytes express Toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis. Br J Dermatol (2003) 1.56
Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. Histopathology (2007) 1.47
Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth. Cancer Res (2011) 1.30
Bacterial biota in reflux esophagitis and Barrett's esophagus. World J Gastroenterol (2005) 1.24
Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression. J Innate Immun (2011) 1.06
Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue. Br J Cancer (2013) 1.06
Flagellin administration protects gut mucosal tissue from irradiation-induced apoptosis via MKP-7 activity. Gut (2011) 1.05
Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus. Clin Cancer Res (2012) 1.02
Toll-like receptor 5 activation promotes migration and invasion of salivary gland adenocarcinoma. J Oral Pathol Med (2010) 1.00
Increased Toll-like receptor 9 expression indicates adverse prognosis in oesophageal adenocarcinoma. Histopathology (2011) 0.99
Flagellin promotes the proliferation of gastric cancer cells via the Toll-like receptor 5. Int J Mol Med (2011) 0.97
Increased expression of toll-like receptors (TLR) 2, 4 and 5 in gastric dysplasia. Pathol Oncol Res (2011) 0.96
Increased expression of Toll-like receptor 5 during progression of cervical neoplasia. Int J Gynecol Cancer (2007) 0.96
Barrett esophagus: histology and pathology for the clinician. Nat Rev Gastroenterol Hepatol (2009) 0.95
Exogenous or endogenous Toll-like receptor ligands: which is the MVP in tumorigenesis? Cell Mol Life Sci (2011) 0.84
Transepithelial leak in Barrett's esophagus. Dig Dis Sci (2006) 0.82
The risk of metachronous neoplasia in patients with serrated adenoma. Am J Clin Pathol (2005) 2.71
Inflammation and prognosis in colorectal cancer. Eur J Cancer (2005) 2.47
Current treatment and outcome of esophageal perforations in adults: systematic review and meta-analysis of 75 studies. World J Surg (2013) 2.21
Treatment of malignant gastroduodenal obstruction with a nitinol self-expanding metal stent: an international prospective multicentre registry. Dig Liver Dis (2011) 1.64
Lymphoid nodular hyperplasia and cow's milk hypersensitivity in children with chronic constipation. J Pediatr (2004) 1.51
Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family. J Biol Chem (2003) 1.19
Morphology and microsatellite instability in sporadic serrated and non-serrated colorectal cancer. J Pathol (2005) 1.13
Expression of carbonic anhydrase IX in breast is associated with malignant tissues and is related to overexpression of c-erbB2. J Pathol (2002) 1.09
Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer. Head Neck (2013) 1.07
Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression. J Innate Immun (2011) 1.06
Carbonic anhydrases in normal gastrointestinal tract and gastrointestinal tumours. World J Gastroenterol (2005) 1.06
Carbonic anhydrase isozymes IX and XII in gastric tumors. World J Gastroenterol (2003) 1.06
Markers of collagen synthesis and degradation are increased in serum in severe sepsis: a longitudinal study of 44 patients. Crit Care (2009) 1.04
Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma. Histopathology (2011) 1.00
Increased Toll-like receptor 9 expression indicates adverse prognosis in oesophageal adenocarcinoma. Histopathology (2011) 0.99
Inhibition of cytokine secretion from adipocytes by 1,25-dihydroxyvitamin D₃ via the NF-κB pathway. FASEB J (2012) 0.99
Estrogen receptor-α and sex steroid hormones regulate Toll-like receptor-9 expression and invasive function in human breast cancer cells. Breast Cancer Res Treat (2011) 0.98
Toll-like receptor-9 expression is inversely correlated with estrogen receptor status in breast cancer. J Innate Immun (2008) 0.98
Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer. Breast Cancer Res Treat (2012) 0.98
Short DNA sequences and bacterial DNA induce esophageal, gastric, and colorectal cancer cell invasion. APMIS (2012) 0.98
Expression of von Hippel-Lindau tumor suppressor and tumor-associated carbonic anhydrases IX and XII in normal and neoplastic colorectal mucosa. World J Gastroenterol (2005) 0.98
Lymphonodular hyperplasia on the mucosa of the lower gastrointestinal tract in children: an indication of enhanced immune response? J Pediatr Gastroenterol Nutr (2002) 0.96
Outcome of patients with esophageal perforations: a multicenter study. World J Surg (2014) 0.96
Budding invasive margin and prognosis in colorectal cancer--no direct association with beta-catenin expression. Eur J Cancer (2006) 0.93
Thyroid hormone receptor beta1 in normal colon and colorectal cancer-association with differentiation, polypoid growth type and K-ras mutations. Int J Cancer (2006) 0.93
Characteristics and significance of colorectal cancer associated lymphoid reaction. Int J Cancer (2013) 0.92
Fluorescence properties of the chromophore-binding domain of bacteriophytochrome from Deinococcus radiodurans. J Phys Chem B (2013) 0.91
For early-stage oral tongue cancer, depth of invasion and worst pattern of invasion are the strongest pathological predictors for locoregional recurrence and mortality. Virchows Arch (2015) 0.91
Esophageal stenting for spontaneous esophageal perforation. J Trauma Acute Care Surg (2012) 0.90
Human leucocyte antigen and TNFalpha polymorphism association in microscopic colitis. Eur J Gastroenterol Hepatol (2008) 0.90
Toll-like receptor 9 expression in the natural history of Barrett mucosa. Virchows Arch (2015) 0.89
DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cells. Breast Cancer Res Treat (2013) 0.87
Inhibition of the mevalonate pathway and activation of p38 MAP kinase are independently regulated by nitrogen-containing bisphosphonates in breast cancer cells. Eur J Pharmacol (2007) 0.87
Expression of a novel carbonic anhydrase, CA XIII, in normal and neoplastic colorectal mucosa. BMC Cancer (2005) 0.86
Assembly of a filamin four-domain fragment and the influence of splicing variant-1 on the structure. J Biol Chem (2011) 0.86
Epidermal wound healing in severe sepsis and septic shock in humans. Crit Care (2009) 0.85
Tight junction proteins in gallbladder epithelium: different expression in acute acalculous and calculous cholecystitis. J Histochem Cytochem (2007) 0.85
17Beta-hydroxysteroid dehydrogenase type 2: independent prognostic significance and evidence of estrogen protection in female patients with colon cancer. J Steroid Biochem Mol Biol (2003) 0.84
The role of C-reactive protein in prediction of the severity of acute diverticulitis in an emergency unit. Scand J Gastroenterol (2015) 0.84
Toll-like receptor 5 and the emerging role of bacteria in carcinogenesis. Oncoimmunology (2013) 0.83
High endothelial venules of the lymph nodes express Fas ligand. J Histochem Cytochem (2004) 0.83
Gastric pit cell hyperplasia and glandular atrophy in carbonic anhydrase IX knockout mice: studies on two strains C57/BL6 and BALB/C. Transgenic Res (2005) 0.83
Nutritional status in adolescents and young adults with screen-detected celiac disease. J Pediatr Gastroenterol Nutr (2005) 0.81
Cathepsin K is present in invasive oral tongue squamous cell carcinoma in vivo and in vitro. PLoS One (2013) 0.81
Colectomy in intensive care patients: operative findings and outcomes. World J Surg (2013) 0.81
Human bone marrow mesenchymal stem cells induce collagen production and tongue cancer invasion. PLoS One (2013) 0.80
Diagnostic accuracy of computed tomography imaging of surgically treated acute acalculous cholecystitis in critically ill patients. J Trauma (2011) 0.79
Interleukin 6 gene polymorphism -174 is associated with the diffuse type gastric carcinoma. Genes Chromosomes Cancer (2013) 0.79
Impact of preoperative organ failures on survival in intensive care unit patients with colectomy. World J Surg (2013) 0.78
Carbonic anhydrase IX in malignant pleural mesotheliomas: a potential target for anti-cancer therapy. Bioorg Med Chem (2012) 0.78
Duodenal cytotoxic lymphocytes in cow's milk protein sensitive enteropathy and coeliac disease. Scand J Gastroenterol (2005) 0.78
Chloroquine has tumor-inhibitory and tumor-promoting effects in triple-negative breast cancer. Oncol Lett (2013) 0.78
HIF-1α and VEGF are associated with disease progression in esophageal carcinoma. J Surg Res (2010) 0.78
BCG vaccine modulates intestinal and systemic response to beta-lactoglobulin. Pediatr Allergy Immunol (2004) 0.78
Fas/Fas ligand-mediated apoptosis in different cell lineages and functional compartments of human lymph nodes. J Histochem Cytochem (2010) 0.78
TLR4 and TLR9 are induced in oral lichen planus. J Oral Pathol Med (2012) 0.78
Toll-like receptor 9 expression in mucoepidermoid salivary gland carcinoma may associate with good prognosis. J Oral Pathol Med (2014) 0.77
Evidence for increased apoptosis of duodenal intraepithelial lymphocytes in cow's milk sensitive enteropathy. J Pediatr Gastroenterol Nutr (2005) 0.77
A similar high level of immunoglobulin A and immunoglobulin G class milk antibodies and increment of local lymphoid tissue on the duodenal mucosa in subjects with cow's milk allergy and recurrent abdominal pains. Pediatr Allergy Immunol (2002) 0.77
Serum and tissue CD23, IL-15, and FasL in cow's-milk protein-sensitive enteropathy and in coeliac disease. J Pediatr Gastroenterol Nutr (2012) 0.77
Effect of heat denaturation on beta-lactoglobulin-induced gastrointestinal sensitization in rats: denatured betaLG induces a more intensive local immunologic response than native betaLG. Pediatr Allergy Immunol (2002) 0.77
Intestinal cytokine mRNA expression in delayed-type cow's milk allergy. J Pediatr Gastroenterol Nutr (2006) 0.77
Differential effects of Ca(2+) on bisphosphonate-induced growth inhibition in breast cancer and mesothelioma cells. Eur J Pharmacol (2006) 0.77
Mucosal pathology of the upper gastrointestinal tract associated with intensive chemotherapy in children: vitamin A supplements do not prevent lesions. Pediatr Hematol Oncol (2002) 0.76
Lymphonodular hyperplasia of the terminal ileum associated with colitis shows an increase gammadelta+ t-cell density in children. Am J Gastroenterol (2002) 0.76
Cytokine gene polymorphism in microscopic colitis association with the IL-6-174 GG genotype. Eur J Gastroenterol Hepatol (2011) 0.76
Cellular turnover and expression of hypoxic-inducible factor in acute acalculous and calculous cholecystitis. Crit Care (2007) 0.76
Skin collagen synthesis is depressed in patients with severe sepsis. Anesth Analg (2010) 0.76
Serum granzymes and CD30 are increased in children's milk protein sensitive enteropathy and celiac disease. J Allergy Clin Immunol (2005) 0.76
Epithelial cell proliferation and glandular atrophy in lymphocytic gastritis: effect of H pylori treatment. World J Gastroenterol (2003) 0.76
Maximal efficiency of PAPNET in the diagnosis of infections in cervicovaginal smears. Diagn Cytopathol (2003) 0.76
Evolution of gastritis in patients with gastric erosions. Scand J Gastroenterol (2005) 0.75
Light-induced structural changes in a monomeric bacteriophytochrome. Struct Dyn (2016) 0.75
Enterocyte and M-cell transport of native and heat-denatured bovine beta-lactoglobulin: significance of heat denaturation. J Agric Food Chem (2006) 0.75
Histopathology of gastric erosions. Association with etiological factors and chronicity. Helicobacter (2011) 0.75
Key architectural changes in tumor-negative lymph nodes from metastatic-free oral cancer patients are valuable prognostic factors. Clin Exp Metastasis (2014) 0.75
Drip-and-ship stroke thrombolysis in the emergency department of a healthcare center - a possibility for those fallen ill in rural settings. Duodecim (1) 0.75
A jaundiced patient at the emergency department. Duodecim (1) 0.75
[Small intestines as an immunological organ]. Duodecim (2002) 0.75
[Radio frequency ablation of Barrett's esophagus--can the risk of esophageal adenocarcinoma be reduced?]. Duodecim (2014) 0.75
Downregulation of the hedgehog receptor PTCH1 in colorectal serrated adenocarcinomas is not caused by PTCH1 mutations. Virchows Arch (2011) 0.75
[Fulminant Clostridium difficile colitis]. Duodecim (2013) 0.75
Sex steroid metabolism in human gastric mucosa: 17 beta-hydroxysteroid dehydrogenase type 2 in normal, inflamed and neoplastic gastric tissues. Anticancer Res (2003) 0.75